Patents by Inventor Qiaofeng Kang

Qiaofeng Kang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted aryl ether compound, preparation method thereof, pharmaceutical composition and use thereof
    Patent number: 11319322
    Abstract: The present invention relates to a compound having the following formula, or a stereoisomer thereof, a prodrug thereof, a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable solvate thereof, preparation method thereof, pharmaceutical composition comprising the same and use of the compound in the manufacture of a medicament for preventing or treating tumor, wherein the substituents are as defined in the specification.
    Type: Grant
    Filed: June 29, 2018
    Date of Patent: May 3, 2022
    Assignee: Xiamen University
    Inventors: Xianming Deng, Ting Zhang, Qiaofeng Kang, Yanru Yang, Xihuan Sun, Zaiyou Yang, Xiaoyang Li, Jingfang Zhang, Jiaji Zhong, Zhou Deng, Chao Dong, Shuang Liu, Li Li, Qingyan Xu, Zhiyu Hu
  • HETEROARYL AMIDE COMPOUNDS, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITIONS THEREOF, AND APPLICATIONS THEREOF
    Publication number: 20200325156
    Abstract: The present invention relates to heteroaryl amide compounds, a preparation method therefor, pharmaceutical compositions thereof and applications thereof, and specifically, relates to a type of compounds having broad-spectrum tumor resistant activity, a preparation method therefor, pharmaceutical compositions containing the compounds, and uses of the compounds in the preparation of drugs for treating tumors.
    Type: Application
    Filed: November 2, 2018
    Publication date: October 15, 2020
    Applicants: Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Xiamen University
    Inventors: Ruibao Ren, Xianming Deng, Min Wu, Ting Zhang, Bo Jiao, Qiaofeng Kang, Wei Huang
  • SUBSTITUTED ARYL ETHER COMPOUND, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF
    Publication number: 20200123162
    Abstract: The present invention relates to a compound having the following formula, or a stereoisomer thereof, a prodrug thereof, a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable solvate thereof, preparation method thereof, pharmaceutical composition comprising the same and use of the compound in the manufacture of a medicament for preventing or treating tumor, wherein the substituents are as defined in the specification.
    Type: Application
    Filed: June 29, 2018
    Publication date: April 23, 2020
    Applicant: Xiamen University
    Inventors: Xianming Deng, Ting Zhang, Qiaofeng Kang, Yanru Yang, Xihuan Sun, Zaiyou Yang, Xiaoyang Li, Jingfang Zhang, Jiaji Zhong, Zhou Deng, Chao Dong, Shuang Liu, Li Li, Qingyan Xu, Zhiyu Hu